Company Filing History:
1 out of 130 
1 out of 2,971 
Years Active: 1990
Title: Innovations in Oncology: The Contributions of Isis C Kettelhut
Introduction: Isis C Kettelhut, based in Brookline, MA, is an accomplished inventor known for her significant contributions to the field of oncology. With one patented innovation to her name, she has made strides in the treatment of malignant and non-malignant diseases, specifically through her research on the combinations of tumor necrosis factors and anti-inflammatory agents.
Latest Patents: Kettelhut's notable patent focuses on "Combinations of tumor necrosis factors and anti-inflammatory agents." This invention outlines methods and combinations for treating various forms of cancer and non-cancerous diseases. It highlights the use of natural or recombinant tumor necrosis factors (TNFs) in combination with non-steroidal anti-inflammatory agents, including indomethacin and ibuprofen. The objective is to facilitate the growth inhibition or destruction of transformed cells while mitigating the toxic side effects associated with high doses of TNFs. This innovative approach enables higher TNF dosages than traditionally tolerated in standard treatment protocols.
Career Highlights: Throughout her career, Kettelhut has worked with prominent organizations that are deeply embedded in medical research and pharmaceutical advancements. Notable among these are Biogen, Incorporated, and Harvard College, institutions recognized for their commitment to innovation in biotechnology and medicine.
Collaborations: Kettelhut has collaborated with esteemed colleagues, including Alfred L. Goldberg and Walter C. Fiers. These partnerships have furthered her research and contributed to the scientific community's understanding of the efficacy of combining TNFs with anti-inflammatory medications.
Conclusion: Isis C Kettelhut's contributions to the field of cancer treatment exemplify the power of innovative thinking in medicine. Her work with tumor necrosis factors and anti-inflammatory agents represents a hopeful advance in therapeutic strategies, potentially transforming how we approach the treatment of various neoplastic diseases. The impact of her innovations serves as an inspiration for future research and development in the field.